SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Eva Perón

PatientEva Perón
Date of birth1994-05-07
IdentifiersMRN HR-ML025-SYN; SSN (made up) 000-25-7316
Document date2026-09-21
AuthorLucía Barragán, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit after cancer treatment. [S]

History of Present Illness

Ms. Perón is a 32-year-old foundation director who comes for her yearly preventive visit, four and a half months after finishing chemoradiation and brachytherapy for stage IIB squamous cell carcinoma of the cervix. Her PET-CT a month ago showed a complete metabolic response. She is back at work full time. The estradiol patch and nightly progesterone have stopped the hot flashes and night sweats, and she uses the vaginal dilator three times a week. Her energy is nearly normal, and she finished the iron course last month. She meets the oncology social worker monthly. She asks what else she should be doing to stay well. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 32
CancerComplete metabolic response on PET-CT a month ago; gynecologic oncology review every three months
Menopause careEstradiol patch and progesterone; symptoms controlled
MoodPHQ-2 0
WorkFull time again

Health risk assessment. Completed by the patient in Spanish on a tablet in the waiting room and reviewed with her by Dr. Barragán in Spanish. [S]

DomainFinding
Self-rated healthGood, and better each month
PsychosocialSupported by a close friend and colleagues; sees the oncology social worker monthly; worries before each scan
Substance useAUDIT-C 1; no drugs
TobaccoNever smoked
Physical activityWalks 30 minutes most days; started a weekly exercise class
NutritionRegular meals; dairy daily; weight back to her usual
SleepSeven hours; night sweats gone
Sexual healthUses the vaginal dilator three times a week and a lubricant; pregnancy is no longer possible after pelvic radiation
Safety at homeFeels safe; no one hurts, threatens, or controls her; no firearm in the home
Road safetyWears a seat belt
Activities of daily livingIndependent

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, weight loss, or night sweats
EyesNegativeNo vision change
Ears, nose, mouth, and throatNegativeNo hearing change or ringing after cisplatin
CardiovascularNegativeNo chest pain or leg swelling
RespiratoryNegativeNo cough or breathlessness
GastrointestinalNegativeBowels normal; no rectal bleeding
GenitourinaryNegativeNo vaginal bleeding or discharge; no urinary symptoms
MusculoskeletalNegativeNo bone or back pain
IntegumentaryNegativeSkin in the radiation field healed; no changing moles
NeurologicalNegativeNo numbness or tingling in the hands or feet
EndocrineNegativeNo hot flashes on the patch
PsychiatricNegativeMood good; PHQ-2 0

12 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairyOne tablet by mouth once dailyOral route2026-02-09 to 2026-08-17completedS
Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a dayOne or two tablets every 6 hours when needed, no more than 6 a dayOral route2026-02-09activeS
Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 daysOne capsule twice daily with food for 5 daysOral route2026-03-27 to 2026-03-31completedS
Cisplatin 40 mg/m2 (64 mg) intravenous infusion once weekly for five weeks during pelvic radiation, with hydration and antiemetic premedication in the infusion center64 mg intravenously once weekly for five dosesIntravenous route2026-03-09 to 2026-04-06completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours when needed for nausea in the days after cisplatinOne tablet every 8 hours when needed for nauseaOral route2026-03-09 to 2026-04-10completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than 8 a dayTwo capsules after the first loose stool, then one after each, no more than 8 a dayOral route2026-03-09 to 2026-05-04completedS
Estradiol 0.1 mg per day transdermal patch, one patch changed twice weeklyOne patch changed twice weeklyTopical route2026-05-18activeS
Progesterone 100 mg oral capsule, one capsule by mouth nightly, to protect any remaining endometrium while on estradiolOne capsule by mouth nightlyOral route2026-05-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-21Body height165cmS
2026-09-21Body weight52.8kgS
2026-09-21Body mass index (BMI) [Ratio]19.4kg/m2S
2026-09-21Systolic blood pressure110mm[Hg]S
2026-09-21Diastolic blood pressure70mm[Hg]S
2026-09-21Heart rate72/minS
2026-09-21Respiratory rate14/minS
2026-09-21Body temperature36.6CelS
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-21Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-09-21Total score [AUDIT-C]1{score}S

Physical Exam

Vital signs recorded on 2026-09-21; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell; weight 52.8 kg, BMI 19.4; blood pressure 110/70
NeckNo lymph nodes; thyroid normal
Lymph nodesNo supraclavicular or inguinal nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation bilaterally
AbdomenSoft and non-tender; no mass
BreastsNo masses
SkinRadiation field healed; no suspicious lesions
PsychiatricBright and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Bleeding after intercourse and between periods, with heavier periods, for about four months, with tiredness and a dull pelvic ache. Never had cervical screening. Speculum examination shows a friable, exophytic mass about 4 cm across on the cervix that bleeds on contact. Punch biopsy, HPV test and cytology taken; urgent gynecologic oncology consultation bookedresolvedconfirmed N93.8S — Synthetic presenting problem linked to her documented abnormal bleeding with anemia; superseded by the diagnosis at the consultation.
Iron deficiency anemia from chronic blood loss: hemoglobin 9.4 g/dL, mean cell volume 72 fL, ferritin 6 ng/mL, with tiredness and breathlessness on stairsresolvedconfirmed D50.0S — Synthetic modern finding linked to her documented anemia from vaginal bleeding.
Invasive squamous cell carcinoma of the cervix, HPV 16 positive: an exophytic tumor about 4.5 cm across with clinical involvement of the left parametrium, not reaching the pelvic wall; pelvic MRI and PET-CT ordered for FIGO 2018 staging. Synthetic modern episode linked to her documented cervical canceractiveconfirmed C53.9S — Synthetic modern diagnosis made at the gynecologic oncology consultation.
Acute cystitis during pelvic chemoradiation: two days of new burning, urgency and cloudy urine on top of mild radiation frequency, without fever or flank pain; urine dipstick positive for leukocyte esterase and nitrite; culture grew Escherichia coli sensitive to nitrofurantoin; neutrophil count and kidney function normal; resolvedresolvedconfirmed N30.00S — Synthetic acute infection; not a historical claim.
Ovarian failure after pelvic radiation, with hot flashes, night sweats, poor sleep and vaginal dryness two weeks after treatment; FSH 72 mIU/mL and estradiol 14 pg/mLactiveconfirmed E89.41S — Synthetic expected effect of pelvic chemoradiation.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today110/70 mmHg
Depression screeningCompleted todayPHQ-2 score 0; PHQ-9 4 a month ago
Unhealthy alcohol use screeningCompleted todayAUDIT-C score 1
Tobacco useCompleted todayNever smoked
Cervical cancer screeningNot indicatedReplaced by gynecologic oncology surveillance after cervical cancer treatment
Contraception and pregnancy intentionNot indicatedPregnancy is no longer possible after pelvic chemoradiation; discussed with her at diagnosis
Intimate partner violence screeningCompleted todayNegative; she feels safe
HIV and hepatitis C screeningUp to dateBoth negative at diagnosis
Diabetes and cholesterol screeningNot indicatedAge 32 with a BMI of 19.4 and no risk factors
Bone health after early menopauseCompleted todayEstrogen therapy in place; calcium-rich diet and weight-bearing exercise advised
Influenza vaccineCompleted todayInactivated influenza vaccine given
COVID-19 vaccineDueDiscussed; she will have the updated vaccine next month
Tetanus, diphtheria, and pertussisUp to dateTdap four years ago
HPV vaccineDeclinedShared decision at age 27 to 45; she declined, understanding that it would not treat her cancer
Measles, mumps, rubella, and hepatitis BUp to dateChildhood series documented

Immunizations given today: Influenza vaccine, 2026-2027 season [S]

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027); Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline (2017); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)

Follow-up: Gynecologic oncology review next month. Next preventive visit in one year. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 18 minutes, in Spanish, with her consent. She named a health care agent, recorded in the confidential part of the chart and not named here. She said that she always wants to be told the truth about her illness herself, first and fully, and that if her cancer ever returned and could not be cured she would want care focused on comfort and on being able to keep working as long as possible. She asked that her wishes be written in Spanish as well as English. To be revisited yearly or if her health changes. [S]